Cleared Traditional

K892197 - ALATOP (TM) CATALOG # AKAL1

K892197 is the FDA 510(k) clearance for ALATOP (TM) CATALOG # AKAL1 by Diagnostic Products Corp.. It is a Class 2 Immunology device (product code DGC) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K892197 · Diagnostic Products Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1989
Decision
60d
Days
Class 2
Risk

K892197 is an FDA 510(k) clearance for the ALATOP (TM) CATALOG # AKAL1. Classified as Ige, Antigen, Antiserum, Control (product code DGC), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on June 2, 1989 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K892197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 1989
Decision Date June 02, 1989
Days to Decision 60 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 104d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DGC Ige, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DGC Ige, Antigen, Antiserum, Control

All 75
Devices cleared under the same product code (DGC) and FDA review panel - the closest regulatory comparables to K892197.
ABBOTT IMX IGE
K895914 · Abbott Laboratories · Nov 1989
MILENIA(TM) TOTAL IGE (MKIE1,5)
K895004 · Diagnostic Products Corp. · Sep 1989
PHARMACIA CAP SYSTEM IGE RIA AND FEIA
K893951 · Pharmacia, Inc. · Jul 1989
N LATEX IGE KIT (IMMUNOGLOBULIN E REAGENTS)
K890530 · Behring Diagnostics, Inc. · Mar 1989
DELFIA (TM) HIGE KIT
K884545 · Pharmacia, Inc. · Nov 1988
PHARMACIA IGE RIA ULTRA
K882625 · Pharmacia, Inc. · Aug 1988